World Journal of Pharmaceutical Research et al …KEYWORDS: Karanj oil, Pongamia Pinnata, UPLC,...
Transcript of World Journal of Pharmaceutical Research et al …KEYWORDS: Karanj oil, Pongamia Pinnata, UPLC,...
www.wjpr.net Vol 6, Issue 17, 2017.
846
Nagaiah et al. World Journal of Pharmaceutical Research
METHOD VALIDATION AND SIMULTANEOUS DETERMINATION
OF TWO BIO-ACTIVE MARKER COMPOUNDS IN PONGAMIA
PINNATA: SEED AND KARANJ OIL BY UPLC-MS
N.M.A. Rasheed1, K. Nagaiah
1*, G. Sowmya Srividya
1 and M.V.N. Kumar Talluri
2
1Organic & Biomolecular Chemistry, CSIR-Indian Institute of Chemical Technology,
Tarnaka, Hyderabad-500007.
2National Institute of Pharmaceutical Education and Research (NIPER), Balanagar,
Hyderabad, 500037.
ABSTRACT
Seed of Pongamia pinnata (Linn.) Merr known as "Karanj" widely
used in traditional system of medicine. Oil from karanj seeds contain
flavonoids which possess diverse pharmacological properties. The seed
oil was subjected to karanj oil-liquid extraction with methanol to
isolate karanjin and pongamol which are active principle of karanj. The
oil mainly used for skin diseases such as psoriasis, eczema and vitiligo
etc. A validated reversed-phase ultra-performance liquid
chromatography method with photodiode array detector was
successfully developed for the first time report to simultaneously
determine two active compounds karanjin and pongamol in karanj seed
extract and its oil. Separation carried through a BEH C18 column by
gradient elution using 0.1% formic acid in water (v/v): methanol:
acetonitrile at 0.2 mL/min. Significant linear correlations were found between component
concentrations and specific chromatographic peak areas. The % R.S.D. values found by the
method indicating precision, range and recovery to be good. Thus the proposed validated
method can be applied as a reference standard for quality control analysis commercial
samples of karanj oil.
KEYWORDS: Karanj oil, Pongamia Pinnata, UPLC, Karanjin, Pongamol.
World Journal of Pharmaceutical Research SJIF Impact Factor 7.523
Volume 6, Issue 17, 846-857. Research Article ISSN 2277–7105
*Corresponding Author
Dr. K. Nagaiah
Senior Principal Scientist,
Organic & Biomolecular
Chemistry, CSIR-Indian
Institute of Chemical
Technology, Tarnaka,
Hyderabad-500007.
Article Received on
22 Oct. 2017,
Revised on 13 Nov. 2017,
Accepted on 04 Dec. 2017,
DOI: 10.20959/wjpr201717-10395
www.wjpr.net Vol 6, Issue 17, 2017.
847
Nagaiah et al. World Journal of Pharmaceutical Research
INTRODUCTION
The seeds of Pongamia pinnata (Linn.) Merr, syn. Pongamia glabra vent. (Family-
Leguminosae) mostly used in traditional Indian system of medicine particularly in Unani and
Ayurveda and popularly known as karanj in urdu, karanja in hindi. It is a medium sized
glabrous tree spread throughout India at an altitude of 1200 m. Macroscopically seed of
karanj appear to be one and rarely two elliptic or somewhat reniform in shape, testa as
reddish leathery. Transverse section of karanj seed shows testa as composed of a layer of
palisade like outer epidermis, filled with brown pigment, covered externally with a thick
cuticle, thick-walled parenchyma cells of two to four layers, and a number of parenchyma
cells containing brown pigment.[1]
All parts of P. pinnata are therapeutically useful for
treating tumors, piles, skin diseases, wounds and ulcers.[2]
The names and structure of the
chemical principles isolated from P. pinnata is given in Fig-1.
Karanjin
Pongamol
Pongarotene
Kanjone
Pongagalabrone
Pongapin
Pinnatin
Pongone
Glabrachalcone
Glabone
Fig. 1: Chemical structures of constituents of P. Pinnata L.[3-5]
www.wjpr.net Vol 6, Issue 17, 2017.
848
Nagaiah et al. World Journal of Pharmaceutical Research
Karanj oil from seeds contain two important compounds karanjin and pongamol, both are
bioactive compounds with important biological attributes. Seed reported to possess
anthelmintic activity, effective in treatment of leprosy, chronic fever, also helps in piles,
relives liver pain, heals ulcers.[6]
Seed extracts possesses antiinflammatory activity,[7]
anti-
oxidative, anti-ulcerogenic properties, analgesic and hypoglycaemic,[8]
also useful in
rheumatism arthritis and scabies[9]
and it is used to treat dermatitis of pet animals[10-11]
and
gastroprotective.[12]
Various herbal remedies separately or along with combination were
recommended in different medical conditions for the cure of skin diseases such as psoriasis,
eczema and vitiligo.[13]
The oil reported to be antihelmintic, styptic and recommended for
opthalmia, leprosy, ulcers, herpes and lumbago. Its oil utilized as a source of biodiesel.[14-15]
Karanj oil reported to contains 5–6% flavonoids, the main active constituents found are
karanjin, (a furano-flavonoid) and pongamol (a diketone) which possess various
pharmacological properties[16]
and their isolation in pure form and efficient quantitative
method with more precise and accurate content in seed extracts, seed oil and also
commercially available oil samples at present a great need.[17]
Karanjin showed pesticidal and
insecticidal properties.[18]
Dermal absorption of karanjin from Jatyadi Taila an oil based
Ayurvedic drug.[19]
The presence of karanjin, pongamol, pongagalabrone, pongapine,
pinnatine and kanjone in Pongamia pinnata which are mainly responsible for various
pharmacological activity.[20]
(Fig-1)
Another use of karanjin oil as starting material for biodiesel, the manufactures do not seem to
remove karanjin, pongamol etc for biodiesel which can be more useful for medicinal purpose
as described above. Karanj oil also used to light lamps, where karanjin, pongamol and other
compounds and other active principles are not required. Biodiesel is prepared by trans-
esterification of karanj oil by heating with NaOH or KOH and methanol. Karanjin is not
desirable in biodiesel because it corrodes the engine parts. If karanjin is removed before, the
biodiesel is efficient. On the other hand, the crude karanjin and pongamol enriched oil as
shown in the present study, could be used in skin ointments.
Earlier few methods were reported by Gore and Satyamoorthy, Shejawal et al.[11,21]
which are
based on conventional HPLC for karanjin only and for both compounds based on dual
wavelength detection and are not validated. The objective of this study was to develop a
validated UPLC method for simultaneous determination of karanjin and pongamol as per ICH
guidelines[22]
at a single wavelength. The seed oil was subjected to karanj oil–liquid
www.wjpr.net Vol 6, Issue 17, 2017.
849
Nagaiah et al. World Journal of Pharmaceutical Research
extraction with methanol to isolate pure compounds of karanjin and pongamol[13]
and
preparation of enriched oil for topical application in the treatment of skin diseases. Till now
no method was reported through UPLC for the estimation of karanjin and pongamol in
commercial or marketed samples to the best of our knowledge. Thus efforts were made to
develop a validated RP-UPLC method by PDA.
MATERIAL AND METHODS
All HPLC grade reagents were used. HPLC-grade methanol, acetonitrile, water, formic acid,
orthophosphoric acid, triflouroacetic acid were used. Marketed Samples of karanj oil such as
Vyas karanj oil and Cold pressed pure karanj oil make Soul-centric was procured and karanj
seeds were procured from the pharmacy, Central Research Institute of Unani Medicine,
Hyderabad and one from local region. Karanjin and pongamol (figure 1) are the pure isolated
compounds from Pongamia pinnata and characterized through spectrophotometric methods
and used as reference standards. These pure compounds available in our laboratory. Karanj
oil is enriched with respect to karanjin etc., by oil/liquid extraction with methanol or
incorporating technical karanjin into oil. Syringe filter PTFE membrane of 0.22 µm pore
size, dia. 25mm (Axiva).
Standard preparation
Standard stock solutions of karanjin and pongamol were made with 10mg in 10ml with
methanol to obtain 1000 μg/ml each separately. Aliquots of stock solutions were prepared by
dilution to obtain required concentrations of 10, 20, 30, 40, 50 g/ml and 2l was injected.
Sample preparation
Samples of karanj oil and seeds were accurately weighed one gram each and transferred in
100 ml beaker, and extracted with 10ml methanol by ultrasonic extraction method for 15 min.
The sample extracts filtered through syringe filter PTFE membrane of 0.22 µm pore size,
stored and used for analysis.
Chromatographic conditions
The mobile phase before delivering was filtered through 0.22 m, PTFE filter and sonicated
with the help of ultrasonicator for 15 minutes. The analysis was carried out under gradient
conditions at a flow rate of 0.2μL/min at temperature 40oC and recorded at 350nm
wavelength.
www.wjpr.net Vol 6, Issue 17, 2017.
850
Nagaiah et al. World Journal of Pharmaceutical Research
Instrument conditions
Acquity UPLC-H class, a quaternary pump, and PDA detector was used. Analyses were
carried on Acquity BEH C18 reversed-phase analytical column (2.1 × 100 mm, 1.7 μm), flow
rate of 0.2 mL/min, at 350 nm wavelength, injection volume 2 μL, column temperature 40°C.
The mobile phase A (0.1% formic acid in water), solvent B (methanol) and solvent C
(acetonitrile) filtered through a 0.22 μm membrane filter; gradient elution as follows: 0 min
40% A, 40% B, 20%C; 1 min 37% A, 48% B, 15%C; 8 min 34% A, 56% B, 10%C; 9 min
30% A, 60% B, 10%C; 11 min 25% A, 65% B, 10%C; 15 min 40% A, 40% B, 20%C; 18
min 40% A, 40% B, 20%C. The data were collected and analyzed using Waters Software
Empower 3.
RESULTS AND DISCUSSIONS
Method development and optimization
Using isocratic elution, all the compounds cannot be effectively separated; thus, gradient
elution was used throughout the study. Suitable wavelength selected for simultaneous
determination of karanjin and pongamol in the range of 200-400 nm and both had good
absorbance at 350 nm. The chromatographic variables were also optimized, including column
temperatures and column types. Optimum separation was eventually achieved with the
reversed-phase Waters Acquity UPLC™ BEH C18 2.1 x 100 mm, 1.7 µm, at 40°C
temperature. To obtain chromatograms with well-resolved peaks and comfortable analysis
time/run, chromatographic conditions such as column temperature, type of reversed-phase
column, extraction solvent, detection wavelength, and mobile phase along with buffer were
optimized. In this study, methanol, acetonitrile and water along with a small amount of
formic acid as buffer was added to the mobile phase. The acid inhibited the ionization of
acidic compounds in the samples to improve peak shape and restrain peak tailing.
Subsequently 0.1% formic acid in the mobile phase significantly improved the retention
behavior and peak shape of the different components in karanj oil samples. The following
optimized chromatographic conditions were obtained for analysis as mobile phase A: (0.1%
FA in water) and B: (methanol) and C: (acetonitrile). Gradient conditions for elution as 0 min
40% A, 40% B, 20%C; 1 min 37% A, 48% B, 15%C; 8 min 34% A, 56% B, 10%C; 9 min
30% A, 60% B, 10%C; 11 min 25% A, 65% B, 10%C; 15 min 40% A, 40% B, 20%C; 18
min 40% A, 40% B, 20%C. The flow rate was 0.2mL/min, and the column temperature was
40°C. A typical UPLC chromatogram as shown in figure 2. The retention times for the
compounds detected in the Karanj oil samples were at karanjin (tR 7.3 min) and pongamol (tR
www.wjpr.net Vol 6, Issue 17, 2017.
851
Nagaiah et al. World Journal of Pharmaceutical Research
13.6 min). Upon LCMS analysis, karanjin and pongamol was detected in the positive mode
were identified and confirmed in standard solution and in the Karanj oil samples through
LCMS data.
Peak1 K
ara
njin
- 7
.388
Peak2 P
ongam
ol -
13.6
48
AU
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00
Fig. 2. UPLC chromatogram of (a) standard mixture, b) UV Spectrum of karanjin and
pongamol of standard and sample c) karanj oil sample.
a: std mix
Karanj oil sample
7.393 Peak9 Karanjin
217.3
260.1
306.3
AU
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
13.642 Peak12 Pongamol
235.6
350.3
AU
0.000
0.010
0.020
0.030
0.040
nm
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00 400.00
7.387 Peak1 Karanjin
217.3
260.1
306.3
AU
0.00
0.20
0.40
0.60
13.648 Peak2 Pongamol
239.3
349.1
AU
0.000
0.010
0.020
0.030
0.040
0.050
nm
220.00 240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00 400.00
Peak1 -
2.5
43
Peak2 -
4.0
51
Peak3 -
4.3
51
Peak4 -
5.1
24
Peak5 -
5.7
08
Peak6 -
6.0
74
Peak7 -
6.6
18
Peak8 -
7.0
00 Peak9 K
ara
njin
- 7
.393
Peak10 -
8.0
83
Peak11 -
13.2
13
Peak12 P
ongam
ol -
13.6
42
Peak13 -
14.0
86AU
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
0.24
0.26
0.28
0.30
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00
b: sample UV spectrum b: std UV spectrum
c:
www.wjpr.net Vol 6, Issue 17, 2017.
852
Nagaiah et al. World Journal of Pharmaceutical Research
System suitability
To ensure adequate performance of the chromatographic system, we evaluated the retention
time (tR), Resolution (RS), number of theoretical plates (N), and tailing factor (T) using
standard solution for karanjin and pongamol such as retention time (tR), Resolution (RS),
number of theoretical plates (N), and tailing factor (T), all parameters were good and in
acceptable limits.
Linearity, limit of detection and limit of quantitation
After establishing the optimum conditions, method validation was performed. Good linear
correlation and high-sensitivity under these chromatographic conditions were confirmed by
the correlation coefficients (R2), limits of detection (LOD), and limits of quantitation (LOQ)
The linearity calibration curves were plotted based on at least five calibration points
performed in triplicate. The correlation coefficient R2 and linear regression equations were
analyzed. Results of regression analyses and the calculated correlation coefficients (R2)
indicated good linearity within concentration ranges for both the investigated compounds at
the wavelengths at 350 nm as given in table 1.
Table 1: Statistical results of linear regression equation analysis in the determination of
the two investigated compounds.
S.no Parameter Karanjin Pongamol
1 Linear Range (μg/ml) 10-50 10-50
2 Regression equation y = 96615x - 699.7 y = 93440x - 64619
3 R2 0.998 0.995
Limits of detection and limits of quantitation under the present chromatographic conditions
were defined as the lowest concentration with the signal-to-noise ratio of 3 and 10 as criteria,
respectively. The LODs for karanjin and pongamol was 0.25 and 1.41 μg/ml respectively and
LOQs for karanjin and pongamol was 0.86 and 4.70 μg/ml respectively.
Precision, repeatability and recovery data
Precision was evaluated by analyzing standard samples. Thus, five individual sample
solutions were analyzed. For each compound the RSD of the mean was calculated and ranged
from 0.13% to 0.60% for intraday precisions. Hence the proposed method was found to be
precise. The results are shown in table 2. The recoveries of karanjin and pongamol were
assessed by spiking known amount each at three different levels ranging 50µg, 100 µg and
150 µg with respect to concentration of karanjin and pongamol in karanj oil samples found
www.wjpr.net Vol 6, Issue 17, 2017.
853
Nagaiah et al. World Journal of Pharmaceutical Research
and further analyzed by UPLC. All estimations were repeated thrice (n=3) and the relative
standard deviations were calculated. The recovery range and %RSD for karanjin and
pongamol were found to be 96.94-99.32% and 100.55-105.25% with %RSD < 0.0018%
respectively as showed in table 2.
Table 2: Precision, Repeatability and Recovery of two compounds.
Karanjin Pongamol
Repeatability
(Mean ± %RSD)
(n=3)
11873382± 0.16 14939121± 0.13
Recovery
(Mean ±%RSD)
(n=3)
99.32 ±0.0018 100.55 ±0.0013
Precision Karanjin Precision Pongamol
Conc.
𝛍g/ml
Intraday (n=3) Inter day
(n=3) Conc.
𝛍g/ml
Intraday (n=3) Inter day
(n=3)
Mean ± %RSD Mean
± %RSD
Mean
± %RSD
Mean
± %RSD
10 97913 ± 0.53 97166 ± 0.86 10 97913 ± 0.53 97166 ± 0.86
20 191663 ± 0.13 192235 ± 0.99 20 191663 ± 0.13 192235 ± 0.99
30 290404 ± 0.28 292826 ± 0.58 30 290404 ± 0.28 292826 ± 0.58
40 377862 ± 0.10 381031 ± 0.65 40 377862 ± 0.10 381031 ± 0.65
50 487890 ± 0.33 494916 ± 1.38 50 487890 ± 0.33 494916 ± 1.38
Similarly the accuracy in determination of the assay of karanj oil sample was checked at five
concentration levels i.e. 10, 20, 30, 40, 50µg/ml each in triplicate for 3 days and the
percentage recoveries are recorded in table-2. % RSDs were calculated to measure the
method reproducibility. Results indicated that the RSDs of all detected compounds were
<1.5%, which indicated that the develop method had good reproducibility. The accuracy of
the method was found to be good with the overall % RSD for recovery at known amount
addition of 50µg, 100 µg and 150 µg levels were all within the limits. This indicates that the
proposed method was found to be accurate.
Karanj oil Sample analysis
The assay of six different samples of P. pinnata and enriched karanj oil was subjected to
methanolic extraction through ultrasonication method separately. Extract was filtered through
0.22μm PTFE syringe filter; thus the solution obtained was diluted to 10 times and used for
analysis. Under the optimized chromatographic conditions the results obtained are
represented in table-3. The corresponding overlay chromatogram of formulations with
separation of peaks in seven batches as shown in figure-3. Results indicated that the UPLC
www.wjpr.net Vol 6, Issue 17, 2017.
854
Nagaiah et al. World Journal of Pharmaceutical Research
method had good precision, repeatability and recovery as shown above and that the
developed assay was reliable and useful for assessing Karanj oil quality. The developed
UPLC-PDA method was also reproducible, highly precise, and thus satisfactory for
quantitative analysis.
Table 3. The content of karanjin and pongamol in karanj oil samples.
AU
0.00
0.10
0.20
0.30
0.40
0.50
Minutes
0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00
Fig. 3. Overlay chromatogram of (1-7) samples of karanj oil.
Sample
code
Sample
name
karanjin pongamol
Retention
time Area
karanjin
content
found
% w/w
Retention
time Area
pongamol
content
found
% w/w
1 AKO Market
karanj oil 7.396 1092110 1.11 13.635 1289441 0.15
2 CPKO
Cold
pressed
karanj oil
7.377 565254 0.57 13.627 1002196 0.11
3 VKO Vyas karanj
oil 7.376 419464 0.43 13.63 511044 0.06
4 KNGS Local seed
samples 7.388 1072271 1.09 13.629 978765 0.11
5PH1
Pharmacy
seeds
sample 1
7.393 1921373 1.95 13.626 2390067 0.27
6 PH2
Pharmacy
seeds
sample 2
7.391 1561014 1.59 13.628 1360519 0.16
7 KEE Karanj
enriched oil 7.391 3409626 3.46 13.639 3964015 4.53
www.wjpr.net Vol 6, Issue 17, 2017.
855
Nagaiah et al. World Journal of Pharmaceutical Research
The amount of karanjin and pongamol in karanj oil were found in the range 0.43-1.95 %w/w
and 0.06-0.27%w/w respectively (table-3). The karanjin and pongamol content in the
enriched karanj oil was 3.46%w/w and 4.53 %w/w respectively (table-3, 7KEE).
CONCLUSION
Karanj oil possess antibacterial, antifungal properties for which it is used externally or
topically on skin to treat or heal fungal skin diseases like itching and eczema etc. Karanj oil
whether marketed or cold pressed and karanj seeds from pharmacy or from local region
which were used in the study shows slight variation in their content of karanjin and pongamol
assessed as shown above. Karanj oil sold commercially be used for medicinal purpose should
contain 3-4 percent of karanjin and pongamol active principle for the efficacy. Thus suitable
skin ointment formulations of karanj oil if made with enriched oil so as to have 3-4 % of
karanjin and pongamol may have high potency. If pure karanjin is used in ointment that
becomes an allopathic ointment which are not suitable to use topically and also to make unani
or ayurvedic based herbal ointment. The study also describes a reversed-phase UPLC-PDA
method was successfully developed and validated following ICH guidelines for the
simultaneous detection of two active marker compounds the karanjin and pongamol in karanj
oil. The study serves as a reference standard for the quality control check for karanj oil
analysis.
ACKNOWLEDGMENT
The author thanks Director, CSIR-Indian Institute of Chemical Technology, Hyderabad for
support and providing the necessary facilities and also thanks to Director General, CCRUM,
New Delhi for giving constant encouragement and support. The author also thank Project
Director, NIPER Hyderabad for providing the LCMS facility.
Conflict of interest: None
REFERENCES
1. The Unani Pharmacopoeia of India Part- I, Volume-I, Department of AYUSH, Ministry
of Health and Family Welfare, Government of India, p. 48.
2. Tanaka T, Linuma M, Fuji Y, Yuki K, Mizuno M. Flavonoids in root and bark of
Pongamia pinnata. Phytochemistry, 1992; 31: 993- 998.
3. Simin K, Ali Z, Khaliq-Uz-Zaman SM, Ahmad VU. Structure and biological activity of a
new rotenoid from Pongamia pinnata, Natural Product Letters, 2002; 16(5): 351-357.
www.wjpr.net Vol 6, Issue 17, 2017.
856
Nagaiah et al. World Journal of Pharmaceutical Research
4. Pavanaram SK, Ramachandra Row L. New flavones from Pongamia pinnata (L.) Merr.:
identification of compound D. Nature, 1955; 176: 1177.
5. Aneja R, Khanna RN, Seshadri TR. 6-Methoxyfuroflavone, a new component of the
seeds of Pongamia glabra. Journal of the Chemical Society, 1963; p.163-168.
6. Warrier PK, Nambiar VPK, Ramakutty C. Indian Medicinal Plants. Vol. IV. Orient
Longman Ltd., Madras, 1995; pp. 339.
7. Singh RK, Pandey BL. Anti-inflammatory activity of seed extracts of Pongamia pinnata
in rats. Indian Journal of Physiology and Pharmacology, 1996; 40: 355-358.
8. Dahanukumar SA, Kulkarni RA, Rege NN. Pharmacology of medicinal plants and natural
products. Indian Journal of pharmacology, 2000; 32: 81-118.
9. Prasad G, Reshmi MV. A manual of medicinal trees. Agrobios India. Propagation
methods. Foundation for revitalization for local health tradition, India, 2003; pp.132.
10. Sridhar NB. Effect of dermovet ointment in treating dermatitis of domestic animals.
Indian Journal of Animal Research, 2009; 43(3): 211-212.
11. Shejawal N, Menon S, Shailajan S. Bioavailability of karanjin from Pongamia pinnata L.
in sprague dawley rats using validated RP-HPLC method. Journal of Applied
Pharmaceutical Science, 2014; 4(3): 010-014.
12. Dharmesh SM, Vismaya, Belagihally SM, Rajashekhar S, Jayaram VB, Kanya S, et al.,
Gastroprotective properties of karanjin from karanja (Pongamia pinnata) seeds; role as
antioxidant and H+, K+-ATpase inhibitor. Evidence-Based Complementary and
Alternative Medicine, 2011; 20: 1-10.
13. Vismaya, Eipeson WS, Manjunatha JR, Srinivas P, Kanyaa TCS. Extraction and recovery
of karanjin: A value addition to karanja (Pongamia pinnata) seed oil. Industrial Crops and
Products, 2010; 32: 118–122.
14. Yadav RD,. Jain SK, Alok S, Prajapati SK, Verma A. Pongamia Pinnata: An overview.
International Journal of Pharmaceutical Sciences and Research, 2011; 2(3): 494-500.
15. Lanjhiyana S, Patra KC, Ahirwar D, Rana AC, Garabadu D, Lanjhiyana SK. Karanjin in
Pongamia pinnata: A novel Indian medicinal plant. Der Pharmacia Sinica, 2012; 3(1):
144-147.
16. Tamrakar AK, Yadav PP, Tiwari P, Maurya R, Srivastava AK. Identification of
pongamol and karanjin as lead compounds with antihyperglycemic activity from
Pongamia pinnata fruits. Journal of Ethnopharmacology, 2008; 118(3): 435-9.
www.wjpr.net Vol 6, Issue 17, 2017.
857
Nagaiah et al. World Journal of Pharmaceutical Research
17. Patel PP, Trivedi ND. Simple, efficient and economic method for isolation and analysis of
karanjin and pongamol from karanja seed oil and screening of antimicrobial potential.
International Journal of Pharmacy and Pharmaceutical Sciences, 2015; 7(7): 248-252.
18. Parmar BS, Gulati KC. Synergists for pyrethrins (II)-karanjin. Indian Journal of
Entomology, 1969; 31: 239–243.
19. Shailajan S, Menon S, Pednekar S, Singh A. Wound healing efficacy of Jatyadi Taila: in
vivo evaluation in rat using excision wound model. Journal of Ethnopharmacology, 2011;
138(1): 99-104.
20. Chopade VV, Tankar AN, Pande VV, Tekade AR, Gowekar NM, Bhandari SR,
Khandake SN. International Journal of Green Pharmacy, 2010; 10: 72-75.
21. Gore VK, Satyamoorthy P. Determination of pongamol and karanjin in karanja oil by
reverse phase HPLC. Analytical Letters, 2000; 33(2): 337-346.
22. Guideline on validation of analytical procedure-methodology. International Conference
on Harmonization, Geneva, Switzerland, 1996.